Goldman Sachs Group Inc. increased its position in Genesis Healthcare, Inc. (NYSE:GEN) by 201.7% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 85,362 shares of the company’s stock after buying an additional 57,065 shares during the period. Goldman Sachs Group Inc. owned approximately 0.09% of Genesis Healthcare worth $225,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the company. Teton Advisors Inc. boosted its stake in shares of Genesis Healthcare by 19.0% in the first quarter. Teton Advisors Inc. now owns 50,000 shares of the company’s stock worth $132,000 after buying an additional 8,000 shares during the period. Teachers Advisors LLC boosted its stake in shares of Genesis Healthcare by 51.2% in the fourth quarter. Teachers Advisors LLC now owns 65,810 shares of the company’s stock worth $280,000 after buying an additional 22,291 shares during the period. Alliancebernstein L.P. boosted its stake in shares of Genesis Healthcare by 2.6% in the first quarter. Alliancebernstein L.P. now owns 83,126 shares of the company’s stock worth $219,000 after buying an additional 2,100 shares during the period. Cambridge Investment Research Advisors Inc. boosted its stake in shares of Genesis Healthcare by 789.4% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 91,802 shares of the company’s stock worth $242,000 after buying an additional 81,480 shares during the period. Finally, TFS Capital LLC boosted its stake in shares of Genesis Healthcare by 477.5% in the first quarter. TFS Capital LLC now owns 156,019 shares of the company’s stock worth $412,000 after buying an additional 129,001 shares during the period. 14.90% of the stock is currently owned by institutional investors and hedge funds.

Shares of Genesis Healthcare, Inc. (GEN) traded down 2.9900% during trading on Tuesday, reaching $0.9701. The company’s stock had a trading volume of 294,146 shares. Genesis Healthcare, Inc. has a 12-month low of $0.95 and a 12-month high of $4.75. The company has a 50 day moving average of $1.36 and a 200 day moving average of $2.19. The company’s market cap is $91.89 million.

WARNING: This story was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another website, it was copied illegally and reposted in violation of US & international trademark and copyright legislation. The original version of this story can be accessed at https://www.watchlistnews.com/goldman-sachs-group-inc-buys-57065-shares-of-genesis-healthcare-inc-gen/1529917.html.

A number of analysts recently issued reports on the company. ValuEngine raised Genesis Healthcare from a “strong sell” rating to a “sell” rating in a report on Thursday, June 8th. Cantor Fitzgerald assumed coverage on Genesis Healthcare in a report on Wednesday, July 5th. They set an “overweight” rating on the stock.

About Genesis Healthcare

Genesis Healthcare, Inc is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services.

Want to see what other hedge funds are holding GEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genesis Healthcare, Inc. (NYSE:GEN).

Institutional Ownership by Quarter for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.